Product Information
AMILORIDE HCL 5 MG TABLET is a generic product labeled by Padagis US LLC, priced at $0.1901 per EA under NDC 00574029201. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Padagis US LLCNDC
00574029201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMILORIDE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA018200FDA Approved
Before 1982
TE Code
AB
On Market Since
4/6/2009
Pharmacological Classes
Price Statistics
The NADAC for AMILORIDE HCL 5 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 56.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1901 per EA |
|---|---|
| All-time high | $0.5589 (Feb 11, 2015) |
| All-time low | $0.1473 (Nov 23, 2022) |
| 52-week high | $0.2035 |
| 52-week low | $0.1898 |
| Median price | $0.2001 |
| Average price | $0.2852 |
| Largest weekly change | -31.5% (Nov 23, 2016) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the amiloride hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
amiloride hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Potassium-sparing Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMILORIDE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AMILORIDE HCL 5 MG TABLET, manufactured by Padagis US LLC, is $0.1901 per EA (NDC 00574029201), effective Sep 30, 2026.
How has the price of AMILORIDE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for AMILORIDE HCL 5 MG TABLET has declined 56.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AMILORIDE HCL 5 MG TABLET?
Since Nov 28, 2013, the NADAC for AMILORIDE HCL 5 MG TABLET has ranged from a low of $0.1473 (Nov 23, 2022) to a high of $0.5589 (Feb 11, 2015), with a median of $0.2001 per EA.
Are there cheaper alternatives to AMILORIDE HCL 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of AMILORIDE HCL 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AMILORIDE HCL 5 MG TABLET?
AMILORIDE HCL 5 MG TABLET (NDC 00574029201) is labeled by Padagis US LLC, and CMS classifies it as a generic product.